Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Convergence between CD98 and integrin-mediated T-lymphocyte co-stimulation.

A P Warren1, K Patel, Y Miyamoto

  • 1Department of Biochemistry, St George's Hospital Medical School, London, UK.

Immunology
|January 29, 2000
PubMed
Summary

The cell surface molecule CD98 (also known as solute carrier 3A2) plays a key role in T lymphocyte activation. Blocking beta1 integrin signaling inhibits CD98 co-stimulatory activity, suggesting convergent signaling pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys.

mAbs·2015
Same author

Grain boundary character distribution of nanocrystalline Cu thin films using stereological analysis of transmission electron microscope orientation maps.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2013
Same author

Laparoscopic kidney transplantation: an initial experience.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Combination of up-flow anaerobic sludge blanket reactor and a novel cascade sponge reactor for sewage treatment.

Water science and technology : a journal of the International Association on Water Pollution Research·2011
Same author

Lower thresholds for diagnosis and management of obesity in British South Asians.

International journal of clinical practice·2011
Same author

A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.

Leukemia·2011

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • CD98 is a heterodimeric glycoprotein expressed on the cell surface.
  • It is rapidly upregulated upon T lymphocyte activation.
  • Monoclonal antibody (mAb) 80A10 recognizes an epitope on CD98.

Purpose of the Study:

  • To investigate the co-stimulatory activity of CD98.
  • To determine the effect of beta1 integrin-blocking antibodies on CD98 co-stimulation.
  • To explore potential convergent signaling mechanisms between CD98 and integrins.

Main Methods:

  • Using monoclonal antibodies (mAbs) 80A10 and 4F2 to target CD98.
  • Employing CD3 antibody to induce T lymphocyte proliferation.
  • Utilizing soluble beta1 integrin antibody 18D3 to block integrin function.

Related Experiment Videos

  • Comparing the effects of 18D3 on CD98 and other non-integrin co-stimulatory molecules.

    • Main Results:

    • mAb 80A10 in combination with CD3 antibody induced proliferation of peripheral blood T lymphocytes.
    • CD98 co-stimulatory activity (mediated by mAb 80A10 or 4F2) was blocked by the soluble beta1 integrin antibody 18D3.
    • Previously, 18D3 was shown to inhibit co-stimulatory activity of specific integrins (alpha4beta1, alpha5beta1, alphaLbeta2, alpha4beta7) but not other non-integrins.
    • CD98 demonstrated unique sensitivity to beta1 integrin-blocking antibodies.

    Conclusions:

    • CD98 is uniquely sensitive to inhibitory effects of beta1 integrin-blocking antibodies.
    • This sensitivity suggests convergent signaling mechanisms between integrins and CD98.
    • CD98 may play a role in regulating integrin-mediated adhesive events.